DUBLIN–(BUSINESS WIRE)–The “Presbyopia Market – A Global and Regional Analysis: Focus on Country and Region – Analysis and Forecast, 2025-2035” report has been added to ResearchAndMarkets.com’s offering. The global presbyopia market is experiencing s…
Author: Business Wire
EyeCare Partners to Showcase Optometric Expertise and Innovation at the American Academy of Optometry (AAO) Academy 2025 Boston
ST. LOUIS–(BUSINESS WIRE)–EyeCare Partners is proud to announce its participation in the American Academy of Optometry (AAO) Academy 2025 Boston.
ReadingGlasses.com and American Mensa Unveil The Mensa Collection: Brilliant Eyewear Inspired by History’s Brightest Minds
DALLAS–(BUSINESS WIRE)–ReadingGlasses.com, a premier online eyewear destination for stylish readers, prescription glasses and sunglasses, has partnered with American Mensa, the high IQ society, to debut The Mensa Collection, a limited-edition line of…
Samsara Vision Announces First Pseudophakic Surgery in the PERSPECTIVE Clinical Trial to Evaluate the Smaller-Incision New-Generation Implantable Miniature Telescope (SING IMT®) in Patients with Previous Cataract Surgery
FAR HILLS, N.J.–(BUSINESS WIRE)– #AMD–Samsara Vision Announces First Pseudophakic Surgery in the PERSPECTIVE Clinical Trial to evaluate SING IMT in Patients with Previous Cataract Surgery
Eye Health America Announces Jay Burkett as Chief Executive Officer; Mary Lou Parisi as Chief Growth Officer
GREENVILLE, S.C.–(BUSINESS WIRE)–Eye Health America announced today Jay Burkett has been named Chief Executive Officer. Mary Lou Parisi, co-CEO, was named Chief Growth Officer.
Broadwood Partners Issues Letter to STAAR Surgical’s Board Questioning Its Judgment in Proposed Sale to Alcon
NEW YORK–(BUSINESS WIRE)–Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”) today issued the following letter to the Board of Directors (the “Board”) of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA). Broadwood,…
STAAR Surgical: Independent Industry Analysts Recognize Merits of Alcon Merger, the Value It Provides, and the Downside Risks Facing STAAR on Standalone Basis
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today highlighted commentary from numerous independent i…
STAAR Surgical Addresses Broadwood Partners’ Flawed, Misleading, and Misinformed Claims
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today issued the following statement with respect to the…
Broadwood Partners Publishes Presentation Detailing Opposition to STAAR Surgical’s Sale to Alcon
NEW YORK–(BUSINESS WIRE)–Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”), holders of approximately 27.5% of the outstanding common stock of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), today announced that…
Perfect Corp. Releases Virtual Try-On for Glasses Update with New In-Platform Product Library Featuring Over 13,000 Pre-Loaded Glasses SKUs
NEW YORK–(BUSINESS WIRE)–Perfect Corp., the leading AI and AR beauty and fashion technology provider and developer of ‘Beautiful AI’ solutions, proudly announces a major update to its Online Service for Virtual Glasses Try-On. The new feature introdu…
Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WALTHAM, Mass.–(BUSINESS WIRE)–Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biopharmaceutical company focused on discovering, developing, and commercializing potential best-in-class medicines for serious and rare diseases, today announced that the C…
Intravitreal Injection of Retinal Progenitor Cells Shows Promise in Preclinical Study for Diabetic Retinopathy
IRVINE, Calif.–(BUSINESS WIRE)–A new preclinical study titled “Intravitreal Transplantation of Retinal Progenitor Cells Improves Outcome Measures in a Rat Model of Diabetic Retinopathy” reports that retinal progenitor cells (RPCs) may provide both fu…
Eye Issues Aren’t Always Obvious
OTTAWA, Ontario–(BUSINESS WIRE)–The Canadian Association of Optometrist (CAO) urges regular comprehensive eye exams for children with a new awareness campaign.
Les troubles de la vision ne sont pas toujours évidents
OTTAWA, Ontario–(BUSINESS WIRE)–L’Association canadienne des optométristes (ACO) encourage les examens de la vue complets réguliers pour les enfants avec une nouvelle campagne.
Les troubles de la vision ne sont pas toujours évidents
OTTAWA, Ontario–(BUSINESS WIRE)–L’Association canadienne des optométristes (ACO) encourage les examens de la vue complets réguliers pour les enfants avec une nouvelle campagne.
Terravet Real Estate Solutions Becomes Terramed Real Estate Solutions Amid Expansion Into High‑Need Medical Specialties
BALA CYNWYD, Pa.–(BUSINESS WIRE)–Terravet Real Estate Solutions rebrands as Terramed, expanding from veterinary into ophthalmology and fertility.
Lumata Health Improves Patient Adherence to Vision-Saving Treatments by Alleviating Barriers to Care
RALEIGH, N.C.–(BUSINESS WIRE)– #ContinuousCare–Lumata Health, the company focused on ending preventable blindness with continuous ophthalmic care for people facing chronic eye disease, today announced the results of its new research report, “Lumata’…
Alcon and STAAR Surgical Announce Expiration of Hart-Scott-Rodino Waiting Period for Alcon’s Acquisition of STAAR
GENEVA & LAKE FOREST, Calif.–(BUSINESS WIRE)–Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), the manufacturer of the Implantable Collamer® Lens (IC…
Aurion Biotech Expands Leadership Team, Promoting Andrew Torres, Ph.D., to Chief Manufacturing Officer and Sterling Chung to Chief Regulatory & Quality Officer
SEATTLE & CAMBRIDGE, Mass. & TOKYO–(BUSINESS WIRE)– #Biotech–Aurion Biotech, a clinical-stage regenerative medicine company with a mission to restore vision to millions of patients, today announced the promotions of Andrew Torres, Ph.D., to Chief Ma…
GenSight Biologics Reports Interim Financial Results for the First Half of 2025
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cent…